Gastric metastasis from hormone receptor–positive breast cancer ten years after radical mastectomy: a case report and literature review - Top-Institutions - MDSpire

Gastric metastasis from hormone receptor–positive breast cancer ten years after radical mastectomy: a case report and literature review

  • By

  • Qiang Zhan

  • Gao Wang

  • Hongxia Wan

  • May 15, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Young Women’s Breast Cancer Study
    Young Women’s Breast Cancer Study

    N/A, N/A

    Key Differentiators

    • Oncology

  • #3

    IEO Breast Cancer Cohort
    IEO Breast Cancer Cohort

    N/A, N/A

    Key Differentiators

    • Oncology

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #5

    Maternal and Child Health Hospital in Jiangxi Province
    Maternal and Child Health Hospital in Jiangxi Province

    Nanchang, Jiangxi

    Key Differentiators

    • Oncology

Original Source(s)

Gastric metastasis from hormone receptor–positive breast cancer ten years after radical mastectomy: a case report and literature review

  • by Qiang Zhan, Gao Wang, Hongxia Wan

  • May 15, 2026

Related Content

Dynamic changes and clinical significance of the gut microbiota and serum metabolites in breast cancer onset, progression and chemotherapy intervention

Dana-Farber Research News 05.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from April 16 - 30.

  • by

  • May 15, 2026

  • 21 min
New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care

New guidance from the American College of Physicians (ACP) recommends biennial mammography screening for average-risk women ages 50 to 74.

  • by

  • May 26, 2026

  • 5 min